2024 HCPCS Code Q2041
Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
TAGS: axicabtagene viable positive preparation leukapheresis autologous therapeutic million
| Short Description | Axicabtagene ciloleucel car+ |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2019 |
| HCPCS Code Added Date | April 01, 2018 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q0243 - Casirivimab and imdevimab
- Q0244 - Casirivi and imdevi 1200 mg
- Q0245 - Bamlanivimab and etesevima
- Q0247 - Sotrovimab
- Q0249 - Tocilizumab for covid-19
- Q0477 - Pwr module pt cable lvad rpl
- Q0478 - Power adapter, combo vad
- Q0479 - Power module combo vad, rep
- Q0480 - Driver pneumatic vad, rep
- Q0481 - Microprcsr cu elec vad, rep
- Q0482 - Microprcsr cu combo vad, rep
- Q0483 - Monitor elec vad, rep
- Q0484 - Monitor elec or comb vad rep
- Q0485 - Monitor cable elec vad, rep
- Q0486 - Mon cable elec/pneum vad rep
- Q0487 - Leads any type vad, rep only
- Q0488 - Pwr pack base elec vad, rep
- Q0489 - Pwr pck base combo vad, rep
- Q0490 - Emr pwr source elec vad, rep
- Q0491 - Emr pwr source combo vad rep